SNDX - Syndax Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SNDX is currently covered by 11 analysts with an average price target of $40.95. This is a potential upside of $23.96 (141.02%) from yesterday's end of day stock price of $16.99.

Syndax Pharmaceuticals's activity chart (see below) currently has 227 price targets and 181 ratings on display. The stock rating distribution of SNDX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.46% with an average time for these price targets to be met of 175.4 days.

Highest price target for SNDX is $57, Lowest price target is $29, average price target is $40.95.

Most recent stock forecast was given by DAVID DAI from UBS on 21-Aug-2026. First documented stock forecast 31-Mar-2016.

Currently out of the existing stock ratings of SNDX, 29 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Oct-2024

$33

$16.01 (94.23%)

$37

1 months 20 days ago
(21-Aug-2026)

0/5 (0%)

$13.35 (67.94%)

Buy Since 03-Jan-2023

$40

$23.01 (135.43%)

$45

2 months ago
(11-Aug-2026)

0/16 (0%)

$19.71 (97.14%)

Buy Since 16-Oct-2025

$38

$21.01 (123.66%)

$40

2 months 6 days ago
(05-Aug-2026)

0/7 (0%)

$18.08 (90.76%)

Buy Since 27-Feb-2026

$46

$29.01 (170.75%)

$46

3 months 26 days ago
(15-Jun-2026)

0/4 (0%)

$27.52 (148.92%)

Buy Since 30-Jan-2023

$31

$14.01 (82.46%)

$34

3 months 29 days ago
(12-Jun-2026)

0/9 (0%)

$12.75 (69.86%)

Show more analysts

Please expand the browser size to see the chart

What is SNDX (Syndax Pharmaceuticals) average time for price targets to be met?

On average it took 175 days for the stock forecasts to be reached, with an average price target met ratio of 22.46%.

Which analyst most recently updated their price target on SNDX (Syndax Pharmaceuticals)?

David Dai

Which analyst has the most public recommendations on SNDX (Syndax Pharmaceuticals)?

David Dai works at UBS and has 6 price targets and 3 ratings on SNDX

Which analyst is the currently most bullish on SNDX (Syndax Pharmaceuticals)?

Yigal Nochomovitz with the highest potential upside of $40.01

Which analyst is the currently most reserved on SNDX (Syndax Pharmaceuticals)?

George Farmer with the lowest potential downside of -$4.31
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?